Alexium International (AJX) Added to S&P Dow Jones' S&P/ASX 300 Index
/EINPresswire.com/ -- PERTH, AUSTRALIA and GREER, SC -- (Marketwired) -- 03/15/16 -- Alexium International Group Limited (Alexium) (ASX: AJX) (OTCQX: AXXIY) is pleased to announced that Standard & Poor's Dow Jones Indices has added Alexium to the S&P/ASX 300 -- effective after the close of market on March 18, 2016.
"This is a significant milestone for Alexium and we are grateful for the continued support and confidence of our shareholders, which has made this achievement possible. Being admitted to the S&P/ASX 300 is an important recognition of our recent strong growth," said Nicholas Clark, Alexium CEO.
For full details, click here to view.
About Alexium
Alexium International Group Limited (ASX: AJX) (OTCQX: AXXIY) holds proprietary patent applications for a process developed initially by the U.S. Department of Defense, which allows for the surface modification and attachment of nano-particles or multiple chemical functional groups to surfaces or substrates to provide functions such as fire retardancy, water proofing, oil proofing, and anti-microbial treatments. Applications under development include but are not limited to textiles, paints, and packaging, glass and building materials. Alexium's fire retardant chemical treatments are currently marketed for different fabric markets under the Alexiflam™, Ascalon™, Nycolon™, Nuvalon™, and Polytron™, Omnitron™ and Bactron™ trademarks.
U.S Contacts:
Nick Clark
Chief Executive Officer
nclark@alexiuminternational.com
U.S.: +1 864.991.6687
Bradi Dobson
Marketing Specialist
BDobson@alexiuminternational.com
U.S. R&D Center:
8 Distribution Court
Greer, SC 29650
T: +1 864.416.1060
F: +1 864.752.6465
U.S. Corporate Office:
148 Milestone Way
Greenville, SC 29615
T: +1 864.603.1165
F: +1 864.752.6465
ABN: 91 064 820 408
ASX: AJX
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
